| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |